Selected highlights from the 50

The recent scientific session of the American College of Cardiology (ACC), held in Orlando, provided a forum for ongoing cardiovascular clinical trials from around the world. The high point was clearly the first ever release of results from the CURE study. The Late-Breaking Clinical Trials sessions also featured results and interim data from other trials such as MIRACLE, CAPRICORN, SVG WRIST, RITZ 2, SoS and PRINCE. New applications for data from the OPUS-TIMI16 trial were discussed and promising results from initial studies into the experimental drug ALT-711 showed the way for further studies.

Data and Resources

Field Value
accessLevel public
bureauCode {009:25}
catalog_@context https://project-open-data.cio.gov/v1.1/schema/catalog.jsonld
catalog_@id https://healthdata.gov/data.json
catalog_conformsTo https://project-open-data.cio.gov/v1.1/schema
catalog_describedBy https://project-open-data.cio.gov/v1.1/schema/catalog.json
identifier https://healthdata.gov/api/views/xsg6-by7q
issued 2025-07-14
landingPage https://healthdata.gov/d/xsg6-by7q
modified 2025-09-06
programCode {009:032}
publisher National Institutes of Health
resource-type Dataset
source_datajson_identifier true
source_hash d3b1cefb26c2f0720d4d235ede54498dec4f497d1e6bdfa5b713b09dadea8250
source_schema_version 1.1
theme {NIH}
Groups
  • AmeriGEOSS
  • National Provider
  • North America
Tags
  • AmeriGEO
  • AmeriGEOSS
  • CKAN
  • GEO
  • GEOSS
  • National
  • North America
  • United States
  • acute-coronary-syndrome
  • cardiology-research
  • cardiovascular-disease
  • clinical-trials
  • nih
isopen False
license_id notspecified
license_title License not specified
maintainer NIH
maintainer_email info@nih.gov
metadata_created 2025-09-24T21:51:35.321018
metadata_modified 2025-09-24T21:51:35.321029
notes The recent scientific session of the American College of Cardiology (ACC), held in Orlando, provided a forum for ongoing cardiovascular clinical trials from around the world. The high point was clearly the first ever release of results from the CURE study. The Late-Breaking Clinical Trials sessions also featured results and interim data from other trials such as MIRACLE, CAPRICORN, SVG WRIST, RITZ 2, SoS and PRINCE. New applications for data from the OPUS-TIMI16 trial were discussed and promising results from initial studies into the experimental drug ALT-711 showed the way for further studies.
num_resources 1
num_tags 13
title Selected highlights from the 50